Multi-cancer early detection tests for cancer screening: a behavioural science perspective

Laura A.V. Marlow; Ninian Schmeising-Barnes; Kate Brain; Sue Duncombe; Kathryn A. Robb; Thomas Round; Saskia C. Sanderson; Jo Waller

doi:10.1016/S1470-2045(22)00161-9

Multi-cancer early detection tests for cancer screening: a behavioural science perspective

Laura A.V. Marlow
, Ninian Schmeising-Barnes
, Kate Brain
, Sue Duncombe
, Kathryn A. Robb
, Thomas Round
, Saskia C. Sanderson
, Jo Waller

Research output: Contribution to journal › Comment/debate

15 Scopus citations

Original language	English
Pages (from-to)	837-839
Number of pages	3
Journal	The Lancet Oncology
Volume	23
Issue number	7
DOIs	https://doi.org/10.1016/S1470-2045(22)00161-9
State	Published - Jul 2022
Externally published	Yes

Access to Document

10.1016/S1470-2045(22)00161-9

Cite this

@article{43701a5ab7e8469f8896c322a35c70b3,

title = "Multi-cancer early detection tests for cancer screening: a behavioural science perspective",

author = "Marlow, \{Laura A.V.\} and Ninian Schmeising-Barnes and Kate Brain and Sue Duncombe and Robb, \{Kathryn A.\} and Thomas Round and Sanderson, \{Saskia C.\} and Jo Waller",

note = "Funding Information: JW reports research income from GRAIL Bio UK, which funds 20\% of her salary and the full salaries of LAVM and NS-B through a contract with King's College London. SD is a lay member of the steering committee and received honorarium payments from the NHS-Galleri trial, which is funded by GRAIL Bio UK to evaluate the Galleri test. KB received funding from the Welsh Government as part of the Health and Care Research Wales. SCS is chief behavioural scientist at Our Future Health. KAR and TR report no competing interests. ",

year = "2022",

month = jul,

doi = "10.1016/S1470-2045(22)00161-9",

language = "English",

volume = "23",

pages = "837--839",

journal = "The Lancet Oncology",

issn = "1470-2045",

publisher = "Elsevier Ltd.",

number = "7",

}

TY - JOUR

T1 - Multi-cancer early detection tests for cancer screening

T2 - a behavioural science perspective

AU - Marlow, Laura A.V.

AU - Schmeising-Barnes, Ninian

AU - Brain, Kate

AU - Duncombe, Sue

AU - Robb, Kathryn A.

AU - Round, Thomas

AU - Sanderson, Saskia C.

AU - Waller, Jo

N1 - Funding Information: JW reports research income from GRAIL Bio UK, which funds 20% of her salary and the full salaries of LAVM and NS-B through a contract with King's College London. SD is a lay member of the steering committee and received honorarium payments from the NHS-Galleri trial, which is funded by GRAIL Bio UK to evaluate the Galleri test. KB received funding from the Welsh Government as part of the Health and Care Research Wales. SCS is chief behavioural scientist at Our Future Health. KAR and TR report no competing interests.

PY - 2022/7

Y1 - 2022/7

UR - https://www.scopus.com/pages/publications/85133304409

U2 - 10.1016/S1470-2045(22)00161-9

DO - 10.1016/S1470-2045(22)00161-9

M3 - Comment/debate

C2 - 35772452

AN - SCOPUS:85133304409

SN - 1470-2045

VL - 23

SP - 837

EP - 839

JO - The Lancet Oncology

JF - The Lancet Oncology

IS - 7

ER -